Publication Name	World Journal of Clinical Cases
Manuscript ID	69489
Country	China

Received	2021-08-05 09:15
Peer-Review Started	2021-08-05 09:20
First Decision by Editorial Office Director	2021-11-06 21:37
Return for Revision	2021-11-06 21:37
Revised	2021-11-12 17:27
Publication Fee Transferred
Second Decision by Editor	2022-01-11 03:44
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2022-01-11 19:48
Articles in Press	2022-01-11 19:48
Edit the Manuscript by Language Editor	2021-12-27 20:50
Typeset the Manuscript	2022-01-25 13:45
Publish the Manuscript Online	2022-02-23 15:51

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cell Biology
Manuscript Type	Case Report
Article Title	Efficacy of EGFR-TKI sequential therapy in patients with EGFR exon 19 insertion-positive non-small-cell lung cancer: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Bin-Bin Shan, Yuan Li, Chang Zhao, Xiao-Qin An and Quan-Mao Zhang
ORCID	Author(s) ORCID Number Bin-Bin Shan http://orcid.org/0000-0002-0968-7000 Yuan Li http://orcid.org/0000-0001-5034-5419 Chang Zhao http://orcid.org/0000-0003-0653-0742 Xiao-Qin An http://orcid.org/0000-0001-5634-4601 Quan-Mao Zhang http://orcid.org/0000-0003-0581-8349
Funding Agency and Grant Number
Corresponding Author	Quan-Mao Zhang, BSc, Chief Physician, Endoscopy Center, Shanxi Tumor Hospital, No. 3, Zhigongxin Street, Xinghualing District, Taiyuan 030000, Shanxi Province, China. hdyunqi@yeah.net
Key Words	Non-small cell lung cancer; Next-generation sequencing; EGFR exon 19 insertion; Afatinib; Case report
Core Tip	We presented a case of non-small cell lung cancer carrying the rare EGFR exon 19 insertion mutation. The patient had a good and durable response to afatinib, which provided clinical evidence for the use of afatinib in these patients.
Publish Date	2022-02-23 15:51
Citation	Shan BB, Li Y, Zhao C, An XQ, Zhang QM. Efficacy of EGFR-TKI sequential therapy in patients with EGFR exon 19 insertion-positive non-small-cell lung cancer: A case report. World J Clin Cases 2022; 10(6): 1883-1888
URL	https://www.wjgnet.com/2307-8960/full/v10/i6/1883.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i6.1883

Full Article (PDF)	WJCC-10-1883.pdf
Full Article (Word)	WJCC-10-1883.docx
Manuscript File	69489_Auto_Edited-JHL-FilipodiaCL.docx
Answering Reviewers	69489-Answering reviewers.pdf
Audio Core Tip	69489-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	69489-Conflict-of-interest statement.pdf
Copyright License Agreement	69489-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	69489-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	69489-Language certificate.pdf
Peer-review Report	69489-Peer-review(s).pdf
Scientific Misconduct Check	69489-Bing-Liu JH-2.jpg
Scientific Misconduct Check	69489-CrossCheck.jpg
Scientific Editor Work List	69489-Scientific editor work list.pdf
CrossCheck Report	69489-CrossCheck report.pdf